• Return to Headlines

Shares of Dexcom Rise to a New 52-Week High

By Shiri Gupta

Shares of Dexcom (NASDAQ:DXCM) traded today at $102.48, breaking its 52-week high. Approximately 180,000 shares have changed hands today, as compared to an average 30-day volume of 932,000 shares.

DexCom Inc. is a medical device company focused on the design and development of continuous glucose monitoring systems for people with diabetes. The Company has developed a small implantable device that continuously measures glucose levels in subcutaneous tissue just under the skin, and a small external receiver to which the sensor transmits glucose levels at specified intervals.

Dexcom share prices have moved between a 52-week high of $102.48 and a 52-week low of $42.62 and are now trading 140% above that low price at $102.11 per share. Over the last five market days, the 200-day moving average (MA) has gone up 0.7% while the 50-day MA has advanced 1.7%.

Based on a current price of $102.11, Dexcom is currently 20.4% above its average consensus analyst price target of $81.25. The stock should discover initial support at its 50-day moving average (MA) of $90.76 and subsequent support at its 200-day MA of $66.21.

SmarTrend recommended that subscribers consider buying shares of Dexcom on November 24th, 2017 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $55.51. Since that recommendation, shares of Dexcom have risen 80.8%. We continue to monitor DXCM for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.

Keywords: 52 week high/lows dexcom

Ticker(s): DXCM